Sheela Foam Ltd

Sheela Foam Ltd

₹ 911 0.75%
02 May - close price
About

Sheela Foam Limited is a leading player in India’s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. [1]

Key Points

Largest Manufacturer of Polyurethane Foam
Sheela Foam is the market leader and the largest manufacturer of Polyurethane Foam in India. [1].
Co. enjoys 30-35% Market Share in the Mattresses segment in India and 40% market share in Australia[2]

  • Market Cap 9,904 Cr.
  • Current Price 911
  • High / Low 1,370 / 900
  • Stock P/E 57.9
  • Book Value 263
  • Dividend Yield 0.00 %
  • ROCE 13.6 %
  • ROE 12.5 %
  • Face Value 5.00

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 8.75% over past five years.
  • Promoter holding has decreased over last 3 years: -7.47%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Consumer Durables Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
826 733 551 786 881 737 701 722 761 729 645 613 879
682 649 513 676 786 665 635 644 685 652 567 547 803
Operating Profit 144 84 38 110 95 72 66 78 76 77 78 66 76
OPM % 17% 11% 7% 14% 11% 10% 9% 11% 10% 11% 12% 11% 9%
16 16 18 18 28 16 18 23 28 18 13 24 32
Interest 5 5 5 4 6 2 5 5 5 7 8 9 25
Depreciation 20 18 19 19 20 24 21 20 22 26 23 22 30
Profit before tax 135 77 33 105 97 62 58 75 77 63 60 60 53
Tax % 26% 25% 23% 27% 31% 20% 27% 29% 20% 27% 28% 26% 27%
100 58 25 77 67 49 43 54 61 46 43 44 31
EPS in Rs 10.17 5.96 2.54 7.83 6.85 5.04 4.31 5.44 6.20 4.66 4.41 4.05 2.83
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
987 1,092 1,221 1,359 1,550 1,680 1,889 2,066 2,121 2,437 2,866 2,873 2,866
931 1,012 1,136 1,268 1,374 1,484 1,672 1,855 1,821 2,073 2,550 2,576 2,569
Operating Profit 56 80 85 91 176 196 217 211 300 364 315 297 297
OPM % 6% 7% 7% 7% 11% 12% 11% 10% 14% 15% 11% 10% 10%
6 14 0 11 16 23 21 28 28 50 79 86 88
Interest 24 23 19 16 12 11 9 10 13 18 17 21 49
Depreciation 25 31 30 28 29 30 35 40 59 73 81 90 101
Profit before tax 12 40 36 58 152 178 193 189 256 324 296 273 236
Tax % 35% 22% 23% 26% 31% 29% 31% 29% 24% 26% 26% 26%
8 31 28 43 105 126 134 134 194 240 219 203 165
EPS in Rs 2.34 9.32 8.57 13.13 32.22 12.86 13.70 13.70 19.82 24.36 22.27 20.62 15.95
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: 9%
3 Years: 11%
TTM: -2%
Compounded Profit Growth
10 Years: 20%
5 Years: 7%
3 Years: 0%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: 6%
3 Years: -4%
1 Year: -13%
Return on Equity
10 Years: 20%
5 Years: 18%
3 Years: 16%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 16 16 16 16 16 24 24 24 24 24 24 49 54
Reserves 122 153 180 229 322 439 573 706 895 1,160 1,368 1,552 2,808
248 214 188 146 115 59 48 31 310 334 466 571 573
157 183 241 289 335 395 398 401 414 551 496 531 574
Total Liabilities 543 567 625 679 788 918 1,043 1,162 1,644 2,069 2,355 2,702 4,008
228 268 252 286 288 318 348 412 851 894 883 865 965
CWIP 41 1 17 8 10 36 52 1 18 33 120 287 333
Investments 5 8 0 0 10 0 98 318 231 411 618 768 1,965
268 290 356 385 481 564 544 432 544 732 734 782 746
Total Assets 543 567 625 679 788 918 1,043 1,162 1,644 2,069 2,355 2,702 4,008

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
60 97 124 147 159 122 134 138 157 254 197 212
-4 -30 -27 -49 -34 2 -80 -246 -287 -208 -306 -267
-64 -56 -53 -59 -25 -67 -20 -27 157 -32 93 56
Net Cash Flow -8 12 45 40 100 57 34 -135 27 13 -17 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 43 35 36 31 28 30 28 27 37 45 34 36
Inventory Days 54 64 61 52 49 59 60 60 81 87 64 71
Days Payable 53 52 57 57 52 64 51 46 55 91 58 55
Cash Conversion Cycle 44 47 40 26 24 25 37 41 63 41 40 51
Working Capital Days 37 31 19 -3 -10 -4 7 14 28 28 30 25
ROCE % 16% 14% 19% 38% 39% 35% 28% 26% 23% 18% 14%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
72.95% 72.95% 72.95% 72.95% 72.95% 72.95% 72.95% 72.95% 72.95% 65.48% 65.48% 65.48%
1.33% 1.43% 2.03% 2.53% 3.11% 3.16% 3.19% 3.26% 3.21% 6.04% 6.12% 6.32%
23.65% 23.72% 23.84% 23.37% 22.84% 22.73% 22.43% 22.28% 21.95% 25.08% 24.99% 24.52%
2.07% 1.90% 1.18% 1.15% 1.10% 1.14% 1.43% 1.50% 1.89% 3.40% 3.40% 3.68%
No. of Shareholders 13,38611,93617,80221,50318,23118,94525,29127,23230,57444,13739,44439,103

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls